Scolaris Content Display Scolaris Content Display

Study flow diagram.
Figures and Tables -
Figure 1

Study flow diagram.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figures and Tables -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 1 Children with caries in the primary teeth at 3 years.
Figures and Tables -
Analysis 1.1

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 1 Children with caries in the primary teeth at 3 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 2 Children with caries in the primary teeth at 5 years.
Figures and Tables -
Analysis 1.2

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 2 Children with caries in the primary teeth at 5 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 3 Decayed primary surfaces at 3 years.
Figures and Tables -
Analysis 1.3

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 3 Decayed primary surfaces at 3 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 4 Filled primary surfaces at 3 years.
Figures and Tables -
Analysis 1.4

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 4 Filled primary surfaces at 3 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 5 Decayed or filled primary surfaces at 3 years.
Figures and Tables -
Analysis 1.5

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 5 Decayed or filled primary surfaces at 3 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 6 Decayed primary surfaces at 5 years.
Figures and Tables -
Analysis 1.6

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 6 Decayed primary surfaces at 5 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 7 Filled primary surfaces at 5 years.
Figures and Tables -
Analysis 1.7

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 7 Filled primary surfaces at 5 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 8 Decayed or filled primary surfaces at 5 years.
Figures and Tables -
Analysis 1.8

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 8 Decayed or filled primary surfaces at 5 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 9 Fluorosis (maxillary teeth) at 5 years.
Figures and Tables -
Analysis 1.9

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 9 Fluorosis (maxillary teeth) at 5 years.

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 10 Fluorosis (mandibular teeth) at 5 years.
Figures and Tables -
Analysis 1.10

Comparison 1 Fluoride supplementation (tablets) versus placebo, Outcome 10 Fluorosis (mandibular teeth) at 5 years.

Summary of findings for the main comparison. Fluoride supplementation (tablets) compared to placebo for pregnant women for preventing dental caries in the primary teeth of their children

Fluoride supplementation (tablets) compared to placebo for pregnant women for preventing dental caries in the primary teeth of their children

Population: pregnant women for preventing dental caries in the primary teeth of their children
Setting: USA
Intervention: fluoride supplementation (tablets)
Comparison: placebo

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

Number of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Risk with placebo

Risk with fluoride supplementation (tablets)

Children with caries in the primary teeth at 3 years

Study population

RR 1.46
(0.75 to 2.85)

938
(1 RCT)

⊕⊝⊝⊝
VERY LOW1, 2

At 5 years RR 0.84
(0.53 to 1.33)

30 per 1000

43 per 1000
(22 to 84)

Decayed or filled primary tooth surfaces at 3 years

The mean decayed or filled surfaces at 3 years was 0.30

MD 0.12 higher
(0.05 lower to 0.29 higher)

938
(1 RCT)

⊕⊝⊝⊝
VERY LOW2, 3

Not significant at 5 years

Fluorosis (maxillary teeth) at 5 years

Study population

RR 1.79
(0.95 to 3.40)

798
(1 RCT)

⊕⊝⊝⊝
VERY LOW1, 2

Fluorosis in mandibular teeth at 5 years RR 0.89
(0.35 to 2.29)

35 per 1000

63 per 1000
(33 to 119)

*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI)

CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio

GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

1Downgraded by 2 for imprecision: few events, and CI included appreciable benefits and harms.
2Downgraded by 1 for risk of bias: high attrition bias, and potential limitations in blinding of outcome assessment are likely to lower confidence in the estimate of effect
3Downgraded by 2 for imprecision: CI included appreciable benefits and harms.

Figures and Tables -
Summary of findings for the main comparison. Fluoride supplementation (tablets) compared to placebo for pregnant women for preventing dental caries in the primary teeth of their children
Comparison 1. Fluoride supplementation (tablets) versus placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Children with caries in the primary teeth at 3 years Show forest plot

1

938

Risk Ratio (M‐H, Fixed, 95% CI)

1.46 [0.75, 2.85]

2 Children with caries in the primary teeth at 5 years Show forest plot

1

798

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.53, 1.33]

3 Decayed primary surfaces at 3 years Show forest plot

1

938

Mean Difference (IV, Fixed, 95% CI)

0.05 [‐0.02, 0.12]

4 Filled primary surfaces at 3 years Show forest plot

1

938

Mean Difference (IV, Fixed, 95% CI)

0.07 [‐0.07, 0.21]

5 Decayed or filled primary surfaces at 3 years Show forest plot

1

938

Mean Difference (IV, Fixed, 95% CI)

0.12 [‐0.05, 0.29]

6 Decayed primary surfaces at 5 years Show forest plot

1

798

Mean Difference (IV, Fixed, 95% CI)

‐0.06 [‐0.17, 0.05]

7 Filled primary surfaces at 5 years Show forest plot

1

798

Mean Difference (IV, Fixed, 95% CI)

0.03 [‐0.28, 0.34]

8 Decayed or filled primary surfaces at 5 years Show forest plot

1

798

Mean Difference (IV, Fixed, 95% CI)

‐0.05 [‐0.42, 0.32]

9 Fluorosis (maxillary teeth) at 5 years Show forest plot

1

798

Risk Ratio (M‐H, Fixed, 95% CI)

1.79 [0.95, 3.40]

10 Fluorosis (mandibular teeth) at 5 years Show forest plot

1

798

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.35, 2.29]

Figures and Tables -
Comparison 1. Fluoride supplementation (tablets) versus placebo